Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Zollinger-Ellison Syndrome 1Tongue Neoplasms 1Stomatitis 1Somatostatinoma 1Radiation Injuries 1Paraganglioma 1Insulinoma 1Head and Neck Neoplasms 1Glucagonoma 1Gliosarcoma 1Glioblastoma 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1

Interventions

Docetaxel 8Radiotherapy 6Filgrastim 5Cisplatin 5Radiotherapy, Intensity-Modulated 3Etoposide 3Erlotinib Hydrochloride 3Chemotherapy, Adjuvant 3Cetuximab 3Capecitabine 3Bevacizumab 3sargramostim 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Gemcitabine 2Cyclophosphamide 2Carboplatin 2Acupuncture Therapy 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1pentetreotide 1oncogene protein E7, Human papillomavirus type 16 1olaparib 1oblimersen 1lutetium Lu 177 dotatate 1etoposide phosphate 1entinostat 1enasidenib 1cevimeline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × Salts × CNS × Clear all
NCT00293462 2021-07-30

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

University of California, San Francisco

Phase 3 Completed
91 enrolled 16 charts
CNSHead & Neck

Head and Neck Neoplasms, Radiation Injuries, Stomatitis, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡